AIHealthcare

Anumana, Inc. is a privately held AI-driven health technology company focused on cardiovascular care. Founded by nference and Mayo Clinic, it develops software-as-a-medical-device solutions that analyze electrocardiogram (ECG) and other cardiovascular data to reveal clinically relevant signals that may not be apparent in conventional interpretation. Its platform supports earlier disease detection, clinical decision-making, and procedural or perioperative guidance. Anumana’s FDA-cleared ECG-AI LEF product uses routine 12-lead ECG data to help detect low ejection fraction. The company has expanded its stated focus beyond ECG diagnostics to include multimodal AI, generative imaging, and real-time procedural-support applications, positioning it as a specialist in AI-enabled cardiovascular diagnostics rather than a general-purpose healthcare AI vendor.